2019. Recombinant deoxyribonucleoside kinase from Drosophila melanogaster can improve gemcitabine based combined gene/chemotherapy for targeting cancer cells. Biomolecules and Biomedicine. 19, 4 (Nov. 2019), 342–349. DOI:https://doi.org/10.17305/bjbms.2019.4136.